Clinical Trials Directory

Trials / Unknown

UnknownNCT02761408

ALDH2 Mutation in Taiwanese Head and Neck Cancer

Correlation Between Radiation Dermatitis/Mucositis and ALDH2 Mutation in Taiwanese Head and Neck Cancer

Status
Unknown
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
Taipei Veterans General Hospital, Taiwan · Other Government
Sex
All
Age
21 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the effect of ALDH2 mutation in radiation associating dermatitis or mucositis in head and neck cancer patients who accept chemoradiation therapy

Detailed description

* One-site audit. The enrolled subject is confirmed by PIs ◦◦Source data is compared to external data sources medical records, either paper or electronic case report forms. * NCI CTCAE v5.0 for AE records * Patient recruitment according to inclusion criteria: 1. Newly diagnosed locally head and neck squamous cell carcinoma; 2. Apply for primary chemoradiation or adjuvant chemoradiation; 3. Signed informed consent * Sample size assessment: 60 subjects will be included in one year for total 120 subjects * Missing data to address situations where variables are reported as missing, unavailable, "non-reported," uninterpretable, or considered missing because of data inconsistency or out-of-range results * Fisher's exact test is for category comparison. Kaplan-Meier analysis is for survival analysis. AE grades will be analyzed according to NCI guideline. Two-side p \< 0.05 is suggested significant.

Conditions

Timeline

Start date
2016-04-01
Primary completion
2018-04-01
Completion
2018-07-01
First posted
2016-05-04
Last updated
2016-05-04

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT02761408. Inclusion in this directory is not an endorsement.